| Trial ID: | L5079 |
| Source ID: | NCT05747664
|
| Associated Drug: |
Dwp16001
|
| Title: |
To Compare the Safety and PK/PD Characteristics of Subjects With Between Hepatic Impairment and Normal Hepatic Function
|
| Acronym: |
|
| Status: |
RECRUITING
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Diabetes Mellitus, Type 2
|
| Interventions: |
DRUG: DWP16001
|
| Outcome Measures: |
Primary: Cmax of DWP16001, Cmax of DWP16001, 0 to 48 hours|AUClast of DWP16001, AUClast of DWP16001, 0 to 48 hours |
|
| Sponsor/Collaborators: |
Sponsor: Daewoong Pharmaceutical Co. LTD.
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE1
|
| Enrollment: |
24
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
|
| Start Date: |
2023-04-13
|
| Completion Date: |
2024-04-30
|
| Results First Posted: |
|
| Last Update Posted: |
2024-04-08
|
| Locations: |
Seoul National University Hospital, Seoul, Korea, Republic of
|
| URL: |
https://clinicaltrials.gov/show/NCT05747664
|
